ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MDNA Medicenna Therapeutics Corporation

0.157
0.00 (0.00%)
May 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Medicenna Therapeutics Corporation MDNA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.157 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.157 0.157
more quote information »

Recent News

Date Time Source Heading
4/30/202414:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
4/26/202414:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
4/25/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
4/22/202415:40EDGAR2Form AW - Amendment Withdrawal Request
4/16/202416:05EDGAR2Form S-8 POS - Securities to be offered to employees in..
4/16/202416:05EDGAR2Form F-3/A - Registration statement by foreign private..
4/16/202416:04EDGAR2Form F-10POS - Post-effective amendment to a F-10EF..
4/09/202413:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
4/04/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/14/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/24/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/09/202409:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/05/202408:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/22/202313:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/09/202307:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
11/08/202309:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/06/202306:00GLOBEMedicenna Announces Promising Single-Agent Response and..
11/03/202311:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
10/27/202306:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
10/25/202314:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202306:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
10/24/202306:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/24/202306:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202307:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202306:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
10/03/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/03/202306:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
9/28/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/28/202316:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
9/28/202309:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/28/202306:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
9/06/202306:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/06/202306:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
8/28/202315:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/28/202315:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/28/202306:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
8/14/202315:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/14/202306:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
8/09/202316:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/08/202308:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/08/202306:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
8/04/202307:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/04/202306:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
8/01/202311:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/01/202308:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
7/28/202307:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/28/202306:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
7/25/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/25/202306:00GLOBEMedicenna Presents at National Brain Tumor Society's..
7/06/202309:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

Delayed Upgrade Clock